128 related articles for article (PubMed ID: 36102632)
21. Does histology influence prognosis in patients with early-stage cervical carcinoma?
Grisaru D; Covens A; Chapman B; Shaw P; Colgan T; Murphy J; DePetrillo D; Lickrish G; Laframboise S; Rosen B
Cancer; 2001 Dec; 92(12):2999-3004. PubMed ID: 11753977
[TBL] [Abstract][Full Text] [Related]
22. Natural history and outcome of neuroendocrine carcinoma of the cervix.
Margolis B; Tergas AI; Chen L; Hou JY; Burke WM; Hu JC; Ananth CV; Neugut AI; Hershman DL; Wright JD
Gynecol Oncol; 2016 May; 141(2):247-254. PubMed ID: 26873865
[TBL] [Abstract][Full Text] [Related]
23. Adenocarcinoma of the uterine cervix: why is it different?
Fujiwara K; Monk B; Devouassoux-Shisheboran M
Curr Oncol Rep; 2014 Dec; 16(12):416. PubMed ID: 25325935
[TBL] [Abstract][Full Text] [Related]
24. Uterine cervix cancer treatment at Radiumhemmet: 90 years' experience. Time trends of age, stage, and histopathology distribution.
Hellman K; Hellström AC; Pettersson BF
Cancer Med; 2014 Apr; 3(2):284-92. PubMed ID: 24421278
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant therapy after radical surgery for stage IB-IIB cervical adenocarcinoma with risk factors.
Seki T; Tanabe H; Nagata C; Suzuki J; Suzuki K; Takano H; Isonishi S; Ochiai K; Takakura S; Okamoto A
Jpn J Clin Oncol; 2017 Jan; 47(1):32-38. PubMed ID: 27677664
[TBL] [Abstract][Full Text] [Related]
26. Beyond Sedlis-A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis.
Levinson K; Beavis AL; Purdy C; Rositch AF; Viswanathan A; Wolfson AH; Kelly MG; Tewari KS; McNally L; Guntupalli SR; Ragab O; Lee YC; Miller DS; Huh WK; Wilkinson KJ; Spirtos NM; Van Le L; Casablanca Y; Holman LL; Waggoner SE; Fader AN
Gynecol Oncol; 2021 Sep; 162(3):532-538. PubMed ID: 34217544
[TBL] [Abstract][Full Text] [Related]
27. What is the difference between squamous cell carcinoma and adenocarcinoma of the cervix? A matched case-control study.
Lee KB; Lee JM; Park CY; Lee KB; Cho HY; Ha SY
Int J Gynecol Cancer; 2006; 16(4):1569-73. PubMed ID: 16884367
[TBL] [Abstract][Full Text] [Related]
28. Trends in incidence and mortality rates of squamous cell carcinoma and adenocarcinoma of cervix--worldwide.
Mathew A; George PS
Asian Pac J Cancer Prev; 2009; 10(4):645-50. PubMed ID: 19827887
[TBL] [Abstract][Full Text] [Related]
29. Morphometric differentiation of squamous cell carcinoma and adenocarcinoma of the cervix.
Wesoła M; Jeleń M
Pol J Pathol; 2015 Dec; 66(4):410-3. PubMed ID: 27003774
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathological characteristics and prognosis of cervical cancer with different histological types: A population-based cohort study.
Meng Y; Chu T; Lin S; Wu P; Zhi W; Peng T; Ding W; Luo D; Wu P
Gynecol Oncol; 2021 Dec; 163(3):545-551. PubMed ID: 34740461
[TBL] [Abstract][Full Text] [Related]
31. Global Cervical Cancer Incidence by Histological Subtype and Implications for Screening Methods.
Wang M; Huang K; Wong MCS; Huang J; Jin Y; Zheng ZJ
J Epidemiol Glob Health; 2024 Mar; 14(1):94-101. PubMed ID: 38170398
[TBL] [Abstract][Full Text] [Related]
32. Prognostic impact of histology in patients with cervical squamous cell carcinoma, adenocarcinoma and small cell neuroendocrine carcinoma.
Intaraphet S; Kasatpibal N; Siriaunkgul S; Sogaard M; Patumanond J; Khunamornpong S; Chandacham A; Suprasert P
Asian Pac J Cancer Prev; 2013; 14(9):5355-60. PubMed ID: 24175825
[TBL] [Abstract][Full Text] [Related]
33. Invasive cervical cancer and screening: what are the rates of unscreened and underscreened women in the modern era?
Subramaniam A; Fauci JM; Schneider KE; Whitworth JM; Erickson BK; Kim K; Huh WK
J Low Genit Tract Dis; 2011 Apr; 15(2):110-3. PubMed ID: 21263352
[TBL] [Abstract][Full Text] [Related]
34. Screening frequency and histologic type influence the efficacy of cervical cancer screening: A nationwide cohort study.
Chiang YC; Chen YY; Hsieh SF; Chiang CJ; You SL; Cheng WF; Lai MS; Chen CA;
Taiwan J Obstet Gynecol; 2017 Aug; 56(4):442-448. PubMed ID: 28805598
[TBL] [Abstract][Full Text] [Related]
35. T2-weighted fast spin-echo MR findings of adenocarcinoma of the uterine cervix: comparison with squamous cell carcinoma.
Chung JJ; Kim MJ; Cho NH; Park S; Lee JT; Yoo HS
Yonsei Med J; 1999 Jun; 40(3):226-31. PubMed ID: 10412333
[TBL] [Abstract][Full Text] [Related]
36. Comparison of clinical outcomes of squamous cell carcinoma, adenocarcinoma, and adenosquamous carcinoma of the uterine cervix after definitive radiotherapy: a population-based analysis.
Zhou J; Wu SG; Sun JY; Li FY; Lin HX; Chen QH; He ZY
J Cancer Res Clin Oncol; 2017 Jan; 143(1):115-122. PubMed ID: 27646608
[TBL] [Abstract][Full Text] [Related]
37. [Squamous cell carcinoma (SCC)--nature and usage in patients with cervical carcinoma].
Bocheva Y; Bochev P; Chaushev B; Ivanov S
Akush Ginekol (Sofiia); 2015; 54(2):29-34. PubMed ID: 25909138
[TBL] [Abstract][Full Text] [Related]
38. STAT3:FOXM1 and MCT1 drive uterine cervix carcinoma fitness to a lactate-rich microenvironment.
Silva LS; Goncalves LG; Silva F; Domingues G; Maximo V; Ferreira J; Lam EW; Dias S; Felix A; Serpa J
Tumour Biol; 2016 Apr; 37(4):5385-95. PubMed ID: 26563366
[TBL] [Abstract][Full Text] [Related]
39. Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma.
Eifel PJ; Burke TW; Morris M; Smith TL
Gynecol Oncol; 1995 Oct; 59(1):38-44. PubMed ID: 7557613
[TBL] [Abstract][Full Text] [Related]
40. Histology as Prognostic Factor in Early-Stage Cervical Carcinoma. Experience in a Third-Level Institution.
Barquet-Muñoz SA; Cruz-Rodríguez E; Cantú De León DF; Isla-Ortiz D; Montalvo-Esquivel G; Herrera-Montalvo LA; Pérez-Plasencia C; Pérez-Montiel D; Herrera-Gómez Á
Rev Invest Clin; 2017; 69(5):286-292. PubMed ID: 29077701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
